MedPath

Efficacy of the combination treatment of epinastine hydrochloride 0.1% and bromfenac sodium ophthalmic solution for allergic conjunctivitis.

Not Applicable
Conditions
conjunctivitis
Registration Number
JPRN-UMIN000043696
Lead Sponsor
Tsurumi University Dental Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

conjunctivitis with Stevens-Johnson syndrome and/or proliferative atopic keratoconjunctivitis contact lens wearers eyes with pretreatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath